Progression of Neuroimaging Features Associated with Dyskeratosis Congenita and Short Telomere Syndrome: A Case Report
Main Article Content
Abstract
Background: Dyskeratosis congenita is a rare genetic disorder resulting from mutations that lead to shortened telomeres and premature cellular aging. Although it classically presents with a triad of mucocutaneous abnormalities, it has diverse clinical manifestations, affecting multiple organ systems. Neurological involvement, often seen in severe variants, constitutes a significant element of the disease’s pathophysiology, highlighting the vast array of observed complications.
Case Presentation: A 5-year-old girl with a known diagnosis of dyskeratosis congenita due to a WRAP53 mutation presents with bloody stools and epilepsy. Her clinical course was marked by gastrointestinal disturbances, hematologic sequelae, and severe hepatic manifestations, including recurrent bleeding episodes.
Discussion: This case highlights the complex interplay between telomere dysfunction and the systemic and neurological manifestations in dyskeratosis congenita. The serial brain MRI findings reveal progressive white matter disease, brain volume loss, and choroid plexus calcifications, indicating a rapid neurodegenerative progression and premature aging. Enhanced surveillance and tailored management strategies are crucial to mitigate disease-associated morbidity.
Conclusion: Dyskeratosis congenita due to a WRAP53 mutation enriches our understanding of its neurodegenerative dimensions and emphasizes the pivotal role of telomeres in systemic and neurological health. Integrating advanced imaging with comprehensive multidisciplinary management improves disease monitoring and optimizes patient care.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Zinsser F. Atrophia cutis reticularis cum pigmentione, dystrophia unguium et leukokeratosis oris Ikonogr Dermatol. 1906;5:219–23
3. Chalkoo Ah, Kaul V, Wani La. Zinsser-Cole-Engmann syndrome: A rare case report with literature review. Journal of Clinical and Experimental Dentistry. Published online 2014:e303-6. doi:10.4317/jced.51274
4. Blackburn EH. Switching and Signaling at the Telomere. Cell. 2001;106(6):661-673. doi:10.1016/s0092-8674(01)00492-5
5. Savage SA, Alter BP. Dyskeratosis Congenita. Hematology/Oncology Clinics of North America. 2009;23(2):215-231. doi:10.1016/j.hoc.2009.01.003
6. Armanios M, Blackburn EH. The telomere syndromes. Nature Reviews Genetics. 2012; 13(10):693-704. doi:10.1038/nrg3246
7. Gadelha RB, Machado CB, Pessoa FMC de P, et al. The Role of WRAP53 in Cell Homeostasis and Carcinogenesis Onset. Current Issues in Molecular Biology. 2022;44(11):5498-5515. doi:10.3390/cimb44110372
8. Nelson ND, Bertuch AA. Dyskeratosis congenita as a disorder of telomere maintenance. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2012;730(1-2):43-51. doi:10.1016/j.mrfmmm.2011.06.008
9. Mason PJ, Bessler M. The genetics of dyskeratosis congenita. Cancer Genetics. 2011;204(12):635-645. doi:10.1016/j.cancergen.2011.11.002
10. Walne AJ, Dokal I. Advances in the understanding of dyskeratosis congenita. British Journal of Haematology. 2009;145(2):164-172. doi:10.1111/j.1365-2141.2009.07598.x
11. Dokal I. Dyskeratosis congenita in all its forms. British Journal of Haematology. 2000;110(4):768-779. doi:10.1046/j.1365-2141.2000.02109.x
12. Zhang M, Cao Y, Wu H, Li H. Brain imaging features of children with Hoyeraal‐Hreidarsson syndrome. Brain and Behavior. 2021;11(5). doi:10.1002/brb3.2079
13. Feldstein J, Fernandez Garcia S. The diagnosis and treatment of dyskeratosis congenita: a review. Journal of Blood Medicine. Published online August 2014:157. doi:10.2147/jbm.s47437
14. Bhala S, Best AF, Giri N, et al. CNS manifestations in patients with telomere biology disorders. Neurology Genetics. 2019;5(6). doi:10.1212/nxg.0000000000000370
15. Glousker G, Touzot F, Revy P, Tzfati Y, Savage SA. Unraveling the pathogenesis of Hoyeraal–Hreidarsson syndrome, a complex telomere biology disorder. British Journal of Haematology. 2015;170(4):457-471. doi:10.1111/bjh.13442
16. Bakar Ö, Işik U, Canpolat C, Alanay Y. Hoyeraal–Hreidarsson Syndrome: An Extremely Rare Dyskeratosis Congenita Phenotype. Pediatric Dermatology. 2015;32(6). doi:10.1111/pde.12693
17. Liu H, Yang Y, Xia Y, et al. Aging of cerebral white matter. Ageing Research Reviews. 2017; 34:64-76. doi:10.1016/j.arr.2016.11.006
18. Xiong YY, Mok V. Age-Related White Matter Changes. Journal of Aging Research. 2011;2011:1-13. doi:10.4061/2011/617927
19. Fujita S, Mori S, Onda K, et al. Characterization of Brain Volume Changes in Aging Individuals With Normal Cognition Using Serial Magnetic Resonance Imaging. JAMA Network Open. 2023;6(6):e2318153. doi:10.1001/jamanetworkopen.2023.18153
20. Bergstrand S, Böhm S, Malmgren H, et al. Biallelic mutations in WRAP53 result in dysfunctional telomeres, Cajal bodies and DNA repair, thereby causing Hoyeraal–Hreidarsson syndrome. Cell Death &; Disease. 2020;11(4). doi:10.1038/s41419-020-2421-4
21. Venteicher AS, Abreu EB, Meng Z, et al. A Human Telomerase Holoenzyme Protein Required for Cajal Body Localization and Telomere Synthesis. Science. 2009;323(5914):644-648. doi:10.1126/science.1165357
22. Mahmoudi S, Henriksson S, Weibrecht I, et al. WRAP53 Is Essential for Cajal Body Formation and for Targeting the Survival of Motor Neuron Complex to Cajal Bodies. PLoS Biology. 2010;8(11):e1000521. doi:10.1371/journal.pbio.1000521
23. Tycowski KT, Shu MD, Kukoyi A, Steitz JA. A Conserved WD40 Protein Binds the Cajal Body Localization Signal of scaRNP Particles. Molecular Cell. 2009;34(1):47-57. doi:10.1016/j.molcel.2009.02.020
24. Vulliamy T, Beswick R, Kirwan M, et al. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proceedings of the National Academy of Sciences. 2008;105(23):8073-8078. doi:10.1073/pnas.0800042105
25. Brailovski E, Tsui H, Chen YB, Velsher L, Liu J, Buckstein R. Previously unreported WRAP53 gene variants in a patient with dyskeratosis congenita. Annals of Hematology. 2021;101(4):907-909. doi:10.1007/s00277-021-04678-7